Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Announces Two Clinical Studies with the Anti-VEGF Monoclonal Antibody IBI305, a Biosimilar Candidate to Avastin (Bevacizumab), Met Primary Endpoints 2018-12-13 08:00
WuXi Biologics Achieves Breakthrough Titer of 51g/L in Cell Culture Productivity 2018-12-12 08:08
Tissue Genesis Introduces State-of-the-Art Icellator(R) X 2018-12-11 23:00
Cathay Industrial Biotech Invests an Additional USD 500 Million to Expand its Production Capacity for New Bio-based Materials 2018-12-11 20:45
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million 2018-12-11 15:00
GenEdit Closes $8.5 million Series Seed Financing 2018-12-11 13:17
Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models 2018-12-11 00:30
Tissue Regeneration Therapeutics and RoosterBio Inc. Form Strategic Alliance to Commercialize Umbilical Cord Tissue Cell Technology 2018-12-10 22:00
WuXi AppTec Expands Site in California for Pharmaceutical R&D Services 2018-12-10 16:00
FDA Grants Orphan-drug Designation for TauRx's LMTX in Frontotemporal Dementia 2018-12-10 09:00
NEX China Helping Enterprises Explore New Directions as Plant Extract Market Rises Rapidly 2018-12-07 15:00
DELopen Announces the Launch of the DELopen Website at DELopen.org 2018-12-07 12:25
Merck in Agreement With Cyclica for AI-augmented Screening Platform to Expand Research Capabilities 2018-12-06 21:32
Global Cord Blood Corporation Announces Results of 2018 Annual General Meeting 2018-12-06 20:00
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market" 2018-12-06 18:20
WuXi Biologics Wins SCRIP Award for "Best Company in an Emerging Market" 2018-12-06 18:12
Tychan Begins Phase I Trials for First Ever Yellow Fever Drug 2018-12-06 18:00
Cedrus' Head of Life Sciences Ms. Kimberly Nearing invited to speak at the BioCentury and Bayhelix's China Healthcare Summit 2018 in Shanghai 2018-12-05 09:00
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-OX40 Monoclonal Antibody IBI101 2018-12-05 08:00
U.S. Department of Commerce Names Anpac Bio 2018 National Minority Health Firm of the Year 2018-12-04 20:45
1 314 315 316 317 318 440